Irune
Ruiz Díaz
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (4)
2021
-
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion
Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218
2019
-
Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors
European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303
2017
-
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Oncogenesis, Vol. 6, Núm. 12
2016
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257